Extracellular magnesium and calcium blockers modulate macrophage activity

Magnes Res. 2016 Mar 1;29(1):11-21. doi: 10.1684/mrh.2016.0398.

Abstract

Magnesium (Mg) possesses anti-inflammatory properties, partly because it antagonizes calcium (Ca) and inhibits L-type Ca channels. Our aim was to determine the effects of different concentrations of extracellular Mg, with or without Ca-channel blockers, in macrophages. A macrophage-like cell line J774.E was cultured in different concentrations of extracellular Mg and exposed to i) the phorbol ester PMA to induce the production of reactive oxygen species ii) lipopolysaccharide to induce the production of pro-inflammatory cytokines, or iii) ovalbumin to study endocytosis. The Ca antagonists verapamil and/or TMB-8 were used to interfere with Ca homeostasis. Different concentrations of extracellular Mg did not impact on endocytosis, while Ca antagonists markedly decreased it. Low extracellular Mg exacerbated, whereas Ca antagonists inhibited, PMA-induced production of free radicals. Ca blockers prevented lipopolysaccharide-induced transcription and release of IL-1β, IL-6 and TNF-α, while extracellular Mg had only a marginal effect. Ca channel inhibitors markedly reduced the activity of J774.E cells, thus underscoring the critical role of Ca in the non-specific immune response, a role which was, in some instances, also modulated by extracellular Mg.

Keywords: calcium; cytokines; macrophages; magnesium; reactive oxygen species.

MeSH terms

  • Animals
  • Calcium Channel Blockers / metabolism
  • Calcium Channel Blockers / pharmacology*
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Macrophages / drug effects*
  • Macrophages / metabolism
  • Magnesium / metabolism
  • Magnesium / pharmacology*
  • Mice
  • Mice, Inbred BALB C
  • Structure-Activity Relationship
  • Verapamil / metabolism
  • Verapamil / pharmacology*

Substances

  • Calcium Channel Blockers
  • Verapamil
  • Magnesium